Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.5K
Overview
45.5K
Active versus Passive Immunity01:31

Active versus Passive Immunity

4.9K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
4.9K
Immunological Memory01:23

Immunological Memory

7.3K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
7.3K
Cancer Vaccines01:30

Cancer Vaccines

539
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
539
Cross-reactivity00:42

Cross-reactivity

31.6K
Overview
31.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

437
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
437

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Surveillance Strategies and Clinical Characteristics of Arboviral Diseases in a Pediatric Cohort in Merida, Mexico, 2021-2023.

The American journal of tropical medicine and hygiene·2026
Same author

Making infectious disease data local and as accessible as the weather forecast.

Nature medicine·2026
Same author

Infectious disease modeling for public health practice: projections, scenarios, and uncertainty in three phases of outbreak response.

American journal of epidemiology·2026
Same author

2024-2025 COVID-19 mRNA Vaccine Effectiveness against Severe Disease.

The Journal of infectious diseases·2026
Same author

Association between COVID-19 vaccine efficacy and epidemic force of infection.

NPJ vaccines·2026
Same author

Infectious disease modeling for public health practice: projections, scenarios, and uncertainty in three phases of outbreak response.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Sep 30, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K

Protecting the herd with vaccination.

Natalie E Dean1, M Elizabeth Halloran2,3

  • 1Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.

Science (New York, N.Y.)
|March 10, 2022
PubMed
Summary
This summary is machine-generated.

COVID-19 vaccines significantly reduce virus transmission, but the exact reduction is dynamic. Ongoing research tracks vaccine effectiveness against SARS-CoV-2 spread over time.

More Related Videos

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

3.7K
Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

2.0K

Related Experiment Videos

Last Updated: Sep 30, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

3.7K
Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

2.0K

Area of Science:

  • Epidemiology
  • Vaccinology
  • Public Health

Background:

  • The emergence of SARS-CoV-2 variants has raised questions about vaccine-induced protection against transmission.
  • Understanding the impact of vaccination on viral spread is crucial for effective public health strategies.

Purpose of the Study:

  • To evaluate the extent to which COVID-19 vaccines decrease the transmission of SARS-CoV-2.
  • To analyze the dynamic nature of vaccine effectiveness in reducing viral spread.

Main Methods:

  • Systematic review of clinical trials and real-world observational studies.
  • Meta-analysis of transmission reduction data across different vaccine types and variants.
  • Longitudinal analysis of vaccine effectiveness over time.

Main Results:

  • Vaccination demonstrably lowers the risk of SARS-CoV-2 transmission.
  • The degree of transmission reduction varies depending on the vaccine, circulating variant, and time since vaccination.
  • Booster doses appear to restore and enhance protection against transmission.

Conclusions:

  • COVID-19 vaccines are effective tools for mitigating viral transmission.
  • Continuous monitoring and updated vaccination strategies are necessary to address evolving viral dynamics and maintain population immunity.